Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Akili (AKLI)

Akili Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKLI
DateTimeSourceHeadlineSymbolCompany
06/03/202421:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AKLIAkili Inc
06/03/202421:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AKLIAkili Inc
06/03/202421:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AKLIAkili Inc
29/02/202421:01Business WireAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
27/02/202407:00Business WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
26/02/202414:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
26/02/202413:47Business WireAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
23/02/202422:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
23/02/202422:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
23/02/202412:57Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AKLIAkili Inc
21/02/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
21/02/202421:05Business WireAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesNASDAQ:AKLIAkili Inc
05/01/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
20/12/202321:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
18/12/202313:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
18/12/202313:00Business WireEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17NASDAQ:AKLIAkili Inc
08/12/202322:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
09/11/202321:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKLIAkili Inc
09/11/202321:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
09/11/202321:02Business WireAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
06/11/202322:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
06/11/202322:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
27/10/202321:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
19/10/202317:27Business WireAkili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ETNASDAQ:AKLIAkili Inc
13/10/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
12/10/202313:00Business WireEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study FindsNASDAQ:AKLIAkili Inc
07/10/202300:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
06/10/202312:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
06/10/202312:00Business WireAkili Announces Leadership TransitionNASDAQ:AKLIAkili Inc
27/09/202312:45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AKLIAkili Inc
 Showing the most relevant articles for your search:NASDAQ:AKLI